Buprenorphine Transdermal Delivery System: Bioequivalence Assessment and Adhesion Performance of Two Patch Formulations

<b>Background and Objective:</b> Buprenorphine is an opioid drug indicated for the management of severe and persistent pain. The buprenorphine transdermal patch provides a non-invasive method of rate-controlled drug release, ensuring constant and predictable drug plasma levels over an extended perio...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Marcelo Gomes Davanço, Miguel Fortuny, Alejandro Scasso, Jessica Meulman, Fernando Costa, Thalita Martins da Silva, Débora Renz Barreto Vianna, Leonardo de Souza Teixeira, Karini Bruno Bellorio, Ana Carolina Costa Sampaio, Celso Francisco Pimentel Vespasiano
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2024-09-01
coleção:	Pharmaceutics
Assuntos:	buprenorphine transdermal delivery system patch opioid bioequivalence adhesion
Acesso em linha:	https://www.mdpi.com/1999-4923/16/10/1249
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!